TY - JOUR AU - Tabar, Ana I AU - Delgado, Julio AU - González-Mancebo, Eloina AU - Arroabarren, Esozia AU - Soto Retes, Lorena AU - Domínguez-Ortega, Javier AU - Spanish Allergy and Clinical Immunology Scientific Society (SEAIC) PY - 2021 DO - 10.1159/000513811 UR - http://hdl.handle.net/10668/17234 T2 - International archives of allergy and immunology AB - The Global Initiative for Asthma Report updated in 2019 stated that potential benefits of allergen immunotherapy (AIT), compared to pharmacological and avoidance options, must be weighed against the risk of adverse effects and the inconvenience and... LA - en KW - Allergy KW - Asthma KW - Clinical practice KW - Immunotherapy KW - Age Factors KW - Allergens KW - Antibody Specificity KW - Asthma KW - Biomarkers KW - Clinical Decision-Making KW - Clinical Trials as Topic KW - Cost-Benefit Analysis KW - Desensitization, Immunologic KW - Disease Management KW - Humans KW - Immunoglobulin E KW - Prognosis KW - Severity of Illness Index KW - Treatment Outcome TI - Recent Advances in Allergen-Specific Immunotherapy as Treatment for Allergic Asthma: A Practical Overview. TY - research article VL - 182 ER -